Satoshi Nakasu1,2, Akifumi Notsu3, Yoko Nakasu4. 1. Division of Neurosurgery, Kusatsu General Hospital, Kusatsu, Japan. neuro-nakasu@kfx.biglobe.ne.jp. 2. Department of Neurosurgery, Shiga University of Medical Science, Ohtsu, Japan. neuro-nakasu@kfx.biglobe.ne.jp. 3. Clinical Research Center, Shizuoka Cancer Center, Nagaizumi, Japan. 4. Department of Neurosurgery, Shiga University of Medical Science, Ohtsu, Japan.
Abstract
BACKGROUND: The chance of incidentally detecting brain tumors is increasing as the utilization of magnetic resonance imaging (MRI) becomes more prevalent. In this background, knowledge is accumulating in relation to the prediction of their clinical sequence. However, their prevalence-especially the prevalence of glioma-has not been adequately investigated according to age, sex, and region. METHOD: We systematically reviewed the articles according to the PRISMA statement and calculated the prevalence of meningiomas and diffuse gliomas in adults using a generalized linear mixed model. Specifically, the differences related to age, sex, and region were investigated. RESULTS: The pooled prevalence of incidental meningiomas in MRI studies was 0.52% (95% confidence interval (CI) [0.34-0.78]) in 37,697 individuals from 36 studies. A meta-regression analysis showed that the prevalence was significantly higher in elderly individuals, women, and individuals outside Asia; this remained statistically significant in the multivariate meta-regression analysis. The prevalence reached to 3% at 90 years of age. In contrast, the prevalence of gliomas in 30,918 individuals from 18 studies was 0.064% (95%CI [0.040 - 0.104]). The meta-regression analysis did not show a significant relationship between the prevalence and age, male sex, or region. The prevalence of histologically confirmed glioma was 0.026% (95%CI [0.013-0.052]). CONCLUSIONS: Most of meningiomas, especially those in elderlies, remained asymptomatic, and their prevalence increased with age. However, the prevalence of incidental gliomas was much lower and did not increase with age. The number of gliomas that developed and the number that reached a symptomatic stage appeared to be balanced.
BACKGROUND: The chance of incidentally detecting brain tumors is increasing as the utilization of magnetic resonance imaging (MRI) becomes more prevalent. In this background, knowledge is accumulating in relation to the prediction of their clinical sequence. However, their prevalence-especially the prevalence of glioma-has not been adequately investigated according to age, sex, and region. METHOD: We systematically reviewed the articles according to the PRISMA statement and calculated the prevalence of meningiomas and diffuse gliomas in adults using a generalized linear mixed model. Specifically, the differences related to age, sex, and region were investigated. RESULTS: The pooled prevalence of incidental meningiomas in MRI studies was 0.52% (95% confidence interval (CI) [0.34-0.78]) in 37,697 individuals from 36 studies. A meta-regression analysis showed that the prevalence was significantly higher in elderly individuals, women, and individuals outside Asia; this remained statistically significant in the multivariate meta-regression analysis. The prevalence reached to 3% at 90 years of age. In contrast, the prevalence of gliomas in 30,918 individuals from 18 studies was 0.064% (95%CI [0.040 - 0.104]). The meta-regression analysis did not show a significant relationship between the prevalence and age, male sex, or region. The prevalence of histologically confirmed glioma was 0.026% (95%CI [0.013-0.052]). CONCLUSIONS: Most of meningiomas, especially those in elderlies, remained asymptomatic, and their prevalence increased with age. However, the prevalence of incidental gliomas was much lower and did not increase with age. The number of gliomas that developed and the number that reached a symptomatic stage appeared to be balanced.
Authors: Jane H Cerhan; Alissa M Butts; Jeremy A Syrjanen; Jeremiah A Aakre; Paul D Brown; Ronald C Petersen; Clifford R Jack; Rosebud O Roberts Journal: Mayo Clin Proc Date: 2019-02 Impact factor: 7.616
Authors: Daniel Bos; Marielle M F Poels; Hieab H H Adams; Saloua Akoudad; Lotte G M Cremers; Hazel I Zonneveld; Yoo Y Hoogendam; Benjamin F J Verhaaren; Vincent J A Verlinden; Jasper G J Verbruggen; Abbas Peymani; Albert Hofman; Gabriel P Krestin; Arnaud J Vincent; Richard A Feelders; Peter J Koudstaal; Aad van der Lugt; M Arfan Ikram; Meike W Vernooij Journal: Radiology Date: 2016-06-23 Impact factor: 11.105
Authors: Ramandeep S Arora; Robert D Alston; Tim O B Eden; Edward J Estlin; Anthony Moran; Jillian M Birch Journal: Neuro Oncol Date: 2008-11-24 Impact factor: 12.300
Authors: Anna Brugulat-Serrat; Santiago Rojas; Nuria Bargalló; Gerardo Conesa; Carolina Minguillón; Karine Fauria; Nina Gramunt; José Luis Molinuevo; Juan Domingo Gispert Journal: BMJ Open Date: 2017-03-24 Impact factor: 2.692